Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Credit agrmnt [a]
Appointed director
CC transcript
Acq. announced
BAXTER INTERNATIONAL INC (BAX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Offer Letter, by and between Baxter International Inc. and Joel Grade",
"BAXTER APPOINTS JOEL GRADE CHIEF FINANCIAL OFFICER"
10/02/2023 8-K Quarterly results
08/21/2023 8-K Resignation/termination of a director
Docs: "BAXTER ANNOUNCES UPDATES TO ITS BOARD OF DIRECTORS"
07/27/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/27/2023 8-K Quarterly results
Docs: "BAXTER REPORTS SECOND-QUARTER 2023 RESULTS"
07/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "SAF E H AR B O R S TAT E M E N T"
06/29/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BAXTER APPOINTS WILLIAM AMPOFO TO ITS BOARD"
05/31/2023 SD Form SD - Specialized disclosure report:
05/09/2023 SC 13G/A MORGAN STANLEY reports a 0.6% stake in BAXTER INTERNATIONAL INC
05/09/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Equity Purchase Agreement, by and among Baxter International Inc., Baxter Healthcare Corporation, Baxter Deutschland Holding GmbH, Gambro Dialysatoren GmbH, Bamboo US BidCo LLC and Blitz 23-317 GmbH",
"Amended and Restated Bylaws",
"Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion",
"BAXTER ANNOUNCES CFO TRANSITION"
05/04/2023 8-K Quarterly results
04/27/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/27/2023 8-K Quarterly results
03/23/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/23/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/13/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "THIRD AMENDMENT",
"THIRD AMENDMENT",
"SECOND GUARANTY AMENDMENT"
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.9% stake in Baxter International Inc.
02/09/2023 10-K Annual Report for the period ended December 31, 2022
02/09/2023 8-K Quarterly results
02/08/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/06/2023 SC 13G/A BlackRock Inc. reports a 10% stake in BAXTER INTERNATIONAL INC
01/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BAXTER ANNOUNCES STRATEGIC ACTIONS TO ENHANCE OPERATIONAL EFFECTIVENESS, ACCELERATE INNOVATION FOR PATIENTS AND DRIVE VALUE FOR SHAREHOLDERS"
10/27/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/27/2022 8-K Quarterly results
09/30/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"First Amendment, to the Credit Agreement, among Baxter International Inc., as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein",
"Second Amendment, to the Credit Agreement, as amended by the First Amendment, among Baxter International Inc., as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein",
"First Amendment, to the Five-Year Credit Agreement, among Baxter International Inc., as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein",
"Second Amendment, to the Five-Year Credit Agreement, as amended by the First Amendment, among Baxter International Inc., as Borrower, JPMorgan Chase Bank, National Association, as Administrative Agent and certain other financial institutions named therein",
"Second Amendment, to the Credit Agreement, as amended by the First Amendment, among Baxter Healthcare SA and Baxter World Trade SRL, as Borrowers, J.P. Morgan SE, as Administrative Agent and certain other financial institutions named therein",
"Fall Stockholder Engagement Presentation (October 2022)"
07/28/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/28/2022 8-K Quarterly results
05/31/2022 SD Form SD - Specialized disclosure report:
05/25/2022 8-K Quarterly results
05/12/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/12/2022 EFFECT Form EFFECT - Notice of Effectiveness:
05/12/2022 EFFECT Form EFFECT - Notice of Effectiveness:
05/06/2022 8-K Material Modifications to Rights of Security Holders, Departure of Directors or Certain Officers; Election of Directors; Appo...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amended and Restated Certificate of Incorporation of Baxter International Inc.",
"Amended and Restated Bylaws"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy